Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $1.80, $0.01 better than the analyst estimate of $1.79. Revenue for the quarter came in at $4.12 billion versus the consensus estimate of $4.1 billion.

Thermo Fisher Scientific sees FY2015 EPS of $7.33-$7.41, versus prior guidance of $7.28-$7.41 and the consensus of $7.38. Thermo Fisher Scientific sees FY2015 revenue of $16.81-16.91 billion, versus prior guidance of $16.72-16.86 billion and the consensus of $16.81 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.